Posted on November 5, 2019 in News
Read original article HERE. Journal of American Medical Association Publishes Study Conducted at Tennessee Oncology OneOncology leaders — Aaron Lyss, MBA and Stephen Schleicher, MD, MBA — and leaders at Tuple Health, published an article in the Journal of American Medical Association (JAMA) Oncology examining the implications of the newly approved standard-of-care immunotherapies within the […]
Read More
Posted on October 29, 2019 in Blog
![]()
Friendship and cancer Today, most people with cancer are treated in the outpatient setting – they don’t have to stay in the hospital. During this time they often need help, support, and encouragement. Many studies have found that cancer survivors with strong emotional support tend to better adjust to the changes cancer brings to their […]
Read More
Posted on October 28, 2019 in News
![]()
Read full article HERE. AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. Stephen Schleicher, MD, MBA, Medical Oncologist, Tennessee Oncology What are your thoughts on the proposed Radiation Oncology Model and the fact that CMS wants […]
Read More
Posted on October 24, 2019 in News
![]()
Read original article HERE. So far, 2019 has been one of the wackier years in the trajectory of the U.S. biosimilar space. It’s been the year in which the entire purpose of the biosimilar industry has been called into question. But it was also the year we started hearing how a number of organizations and […]
Read More
Posted on October 22, 2019 in News
Read More
